U.S., Oct. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07220863) titled 'Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai' on Oct. 21.
Brief Summary: Prospective observational study evaluating the safety and accuracy of Feminai 1.0, an at-home adhesive patch that measures skin temperature and electrical impedance to map each breast. Up to 300 women (ages 25-75) undergoing screening will have one study visit; Feminai results will be compared with mammography and, when available, biopsy to assess sensitivity and negative predictive value. Feminai is investigational, intended to support clinical decision-making, and does not replace standard diagnostic tests.
Study Start Date: Oct. 0...